Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 2010

View Archived Issues

Phase III trial data support safety and tolerability of tafenoquine in malaria prophylaxis

Elevated GDF-15 identified as predictor of mortality in acute reperfused STEMI

GlaxoSmithKline describes potent, orally bioavailable CXCR4 antagonist for HIV-1

Genome-wide RNAi screen reveals drug targets for influenza viruses

Amira Pharmaceuticals describes novel prostaglandin D2 receptor antagonists

New Rho-associated protein kinase inhibitors disclosed

Novel TNF-alpha production inhibitors claimed by sanofi-aventis

PLK-1 inhibitors for the treatment of cancer described by Roche

Monoclonal antibody against integrin alphaV/beta3 reduces atherosclerotic lesions in diabetic pigs

Plant-produced monoclonal antibody protects mice against West Nile virus infection

Noninvasive CMR technique allows assessment of diffuse myocardial fibrosis

GSK reflects on fourth quarter and highlights of 2009

Tioga raises funds for phase III asimadoline trial in D-IBS

Paladin amends R&D agreement with Isotechnika for diagnostic products

Phase II oral interferon trial indicates benefit in preventing influenza-like illness

SurModics to terminate license agreement with Ambrilia Biopharma

Dynavax and GSK select candidate in endosomal TLR inhibitor program

Stem Cell Therapeutics provides update on modified REGENESIS trial

Thallion and LFB sign agreement to develop STEC infection therapy

Immune Targeting Systems secures funds to develop FP-01 universal flu vaccine

FDA accepts for filing Jazz Pharmaceuticals' NDA for sodium oxybate for fibromyalgia

Chugai licenses Roche's Hedgehog pathway inhibitor RG-3616 in Japan

FDA grants priority review to Novartis' Tasigna for newly diagnosed Ph+CML

FDA grants orphan drug status to EntreMed's ENMD-2076 for acute myeloid leukemia

Novel N-type calcium channel blockers claimed by Lectus Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...